Subasa Chandra Bishwal Selected Research

Complement C9 (Complement Component 9)

1/2022

Troxerutin-Mediated Complement Pathway Inhibition is a Disease-Modifying Treatment for Inflammatory Arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Subasa Chandra Bishwal Research Topics

Disease

2	Tuberculosis (Tuberculoses) 04/2016 - 04/2015
1	Arthritis (Polyarthritis) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Pulmonary Tuberculosis 04/2015

Drug/Important Bio-Agent (IBA)

1	Complement System Proteins (Complement)IBA 01/2022
1	Complement C9 (Complement Component 9)IBA 01/2022
1	troxerutinIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2022
1	ProteomeIBA 01/2022
1	Ethambutol (Myambutol)FDA LinkGeneric 04/2016
1	Phenylalanine (L-Phenylalanine)FDA Link 04/2015
1	Tyrosine (L-Tyrosine)FDA Link 04/2015

Therapy/Procedure

1	Oral Administration 01/2022
1	Therapeutics 04/2015